Navigation Links
Tianyin Pharmaceutical Co., Inc. to Host First Quarter of Fiscal Year 2011 Earnings Conference Call on Thursday, November 11, 2010 at 9:00 a.m. ET
Date:11/8/2010

CHENGDU, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a pharmaceutical company that develops, manufactures and sells patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced that the senior management will host the earnings conference call for the first quarter of fiscal year 2011 ending September 30, 2010 at 9:00 a.m. ET on Thursday, November 11, 2010.

Interested parties may access the call by dialing +1-877-941-4774 (U.S.), or +1-480-629-9764 (International). The conference ID is 4384159. It is advisable to dial in approximately 5 minutes prior to the start of the call.

A replay will be available from 12 noon ET on November 11, 2010 till November 25, 2010 by dialing 1-877-870-5176 (U.S.) or 1-858-384-5517 (International), Replay Pin Number: 4384159.

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at the following link: http://viavid.net/dce.aspx?sid=00007DBB

About Tianyin Pharmaceutical

Tianyin Pharmaceutical Co., Inc., headquartered at Chengdu, China, specializes in the development, manufacturing, marketing and sale of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. Tianyin currently manufactures and markets a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective National Reimbursement List, 7 are included in the Essential Drug List of China. Tianyin has a pipeline of 10 products pending SFDA approval targeting cardiovascular conditions, women's health, immune system and respiratory disorders. Tianyin has an extensive nationwide distribution network with 730 sales representatives out of totaled 1,365 employees. For more
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
2. Tianyin Corporate Presentation Updated
3. Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6
4. Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
5. Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET
6. Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
7. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
8. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
9. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
10. Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
11. EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Rolta gab ... Sadara Chemical Company (Sadara) erhalten zu haben, ... des integrierten Chemiekomplexes von Sadara in Jubail ... im Wert von mehreren Millionen Dollar stellt ... dessen Wert sich ebenfalls auf mehrere Millionen ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... N.C. , July 21 /PRNewswire-FirstCall / -- SPX ... completed the acquisition of the Anhydro business, a Soeborg, Denmark ... dewatering plants and equipment.  The terms of the transaction were not ... Anhydro ...
... DETROIT , July 21 Caraco Pharmaceutical ... shipping bupropion hydrochloride extended release tablets. This product was ... (FDA) for Sun Pharma,s Abbreviated New Drug Application (ANDA). ... mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline,s ...
Cached Medicine Technology:SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... Temecula Valley Southern California Wine Country, ... Wine Country artisan food and wine experiences combine ... nourishing. Savor like locals at Briar Rose, Cougar, ... EAT Marketplace, Palumbo’s Ristorante, Robin’s Nest, Old Town ... Kimberly Adams, president and CEO, Visit Temecula Valley ...
(Date:7/23/2014)... In an effort to help advance ... Disease” at the state level, the National Alliance ... of America (AFA) this week released a white ... and the need for wide-scale implementation of state plans ... The white paper outlines recommendations for both ...
(Date:7/23/2014)... living with multiple chronic medical conditions, a new study ... Health finds that the more ailments you have after ... one of the first to examine the burden of ... may help explain why increases in life expectancy among ... findings, based on an analysis of 1.4 million Medicare ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... of the AMA,board, HONOLULU, Hawaii, Nov. 13 ... Inc., has been newly elected,to the American Medical Association ... today. Mr. Kay will be the,only non-physician member on ... the position., Mr. Kay has spent his career ...
... Nov. 13 Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: ... Directors has approved the recommendation of its Special,Committee ... Nastech,s,wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent ... related to,RNA interference ("RNAi") into MDRNA. The new ...
... BOTHELL, Wash., Nov. 13 Nastech,Pharmaceutical Company ... its,corporate restructuring initiatives aimed at reducing operating expenses,and ... its,subsidiary, MDRNA, Inc., as an independent, separately financed ... Phase 2 clinical and partnered,programs as well as ...
... (SWX:,ROG.VX; RO.S) confirmed today that it has entered into ... VMSI ) and that it,will commence due diligence. Roche ... with respect to the acquisition of Ventana will be,reached. ... offer to acquire all of the,outstanding common shares of ...
... of sound in medicine has a long history. Doctors have ... human body since the early 19th century, and ultrasound imaging ... the United States typically know the gender of their offspring ... pregnancy. , Now scientists are finding many more advanced applications ...
... A gene linked to pediatric brain tumors is an essential ... of Medicine in St. Louis have found. , The study, ... neurofibromatosis 1 (NF1) gene helps push stem cells down separate ... brain cells: support cells known as astrocytes and brain neurons. ...
Cached Medicine News:Health News:Fortune 500 Executive Elected to AMA Board of Trustees 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 3Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 4Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 2Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 3Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 4Health News:Roche Confirms Commencement of Due Diligence with Ventana 2Health News:Roche Confirms Commencement of Due Diligence with Ventana 3Health News:Roche Confirms Commencement of Due Diligence with Ventana 4Health News:Sound medicine at Acoustics Meeting 2Health News:Sound medicine at Acoustics Meeting 3Health News:Sound medicine at Acoustics Meeting 4Health News:Sound medicine at Acoustics Meeting 5Health News:Sound medicine at Acoustics Meeting 6Health News:Sound medicine at Acoustics Meeting 7Health News:Sound medicine at Acoustics Meeting 8Health News:Cancer gene drives pivotal decision in early brain development 2Health News:Cancer gene drives pivotal decision in early brain development 3
Fulgurating Electrode, 3 F...
... Flexible CystoNephroscope is used for percutaneous and ... practice. The large 6.4 Fr (2.1 mm) ... operating instruments for therapeutic applications. The flexible ... covered tip provide fast, less traumatic access ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: